Trifluridine/Tipiracil Plus Bevacizumab for Third-Line Treatment of Refractory Metastatic Colorectal Cancer: The Phase 3 Randomized SUNLIGHT Study
This story is reported by OncLive. Read what other outlets are saying below, then open the original report for full details.